» Authors » Vidar Halsteinli

Vidar Halsteinli

Explore the profile of Vidar Halsteinli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 411
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jabakhanji S, Valentelyte G, Manke-Reimers F, Halsteinli V, Odegard R, Martin A, et al.
Appl Health Econ Health Policy . 2025 Feb; 23(2):161-169. PMID: 39893334
Economic evaluations of obesity interventions are critical to informing policymakers and clinical practitioners about best-value prevention and treatment interventions. However, existing studies often fail to measure appropriate outcomes over sufficient...
2.
Hagman E, Halsteinli V, Putri R, Hansen Edwards C, Waaler Bjornelv G, Marcus C, et al.
BMC Med . 2025 Jan; 23(1):33. PMID: 39838331
Background: Pediatric obesity is a growing global health challenge, with long-term implications for individuals and healthcare systems. Existing studies on the association between pediatric obesity and healthcare use in adulthood...
3.
Slaaen M, Royset I, Saltvedt I, Gronberg B, Halsteinli V, Dohl O, et al.
BMC Med . 2024 Jun; 22(1):232. PMID: 38853251
Background: Geriatric assessment and management (GAM) improve outcomes in older patients with cancer treated with surgery or chemotherapy. It is unclear whether GAM may provide better function and quality of...
4.
Hansen Edwards C, Bjorngaard J, Kinge J, Vie G, Halsteinli V, Odegard R, et al.
Health Econ Rev . 2024 Jun; 14(1):36. PMID: 38822866
Background: Earlier studies have estimated the impact of increased body mass index (BMI) on healthcare costs. Various methods have been used to avoid potential biases and inconsistencies. Each of these...
5.
Khan Z, Kidholm K, Pedersen S, Haga S, Drozd F, Sundrehagen T, et al.
Pharmacoeconomics . 2024 Mar; 42(6):663-678. PMID: 38530596
Introduction: The rate of development and complexity of digital health interventions (DHIs) in recent years has to some extent outpaced the methodological development in economic evaluation and costing. Particularly, the...
6.
Aasdahl L, Fimland M, Bjornelv G, Gismervik S, Johnsen R, Vasseljen O, et al.
J Occup Rehabil . 2023 Mar; 33(3):463-472. PMID: 36949254
Purpose: To evaluate the cost-effectiveness and cost-benefit of inpatient multimodal occupational rehabilitation (I-MORE) compared to outpatient acceptance and commitment therapy (O-ACT) for individuals sick listed due to musculoskeletal- or common...
7.
Bolme S, Austeng D, Morken T, Follestad T, Halsteinli V
BMC Health Serv Res . 2023 Mar; 23(1):229. PMID: 36890535
Background: Anti-vascular endothelial growth factor is a medicine administered intravitreally by an injection to maintain visual acuity in patients with a variety of retinal diseases. The demand for this treatment...
8.
Moljord I, Stensvag K, Halsteinli V, Rise M
BMC Health Serv Res . 2021 Dec; 21(1):1310. PMID: 34872531
Background: Self-referral to inpatient treatment (SRIT) is built on user participation and patient autonomy. SRIT was conducted for patients with severe mental disorders in a Norwegian Community Mental Health Centre....
9.
Royset I, Saltvedt I, Rostoft S, Gronberg B, Kirkevold O, Oldervoll L, et al.
J Geriatr Oncol . 2021 Nov; 13(3):363-373. PMID: 34776384
About 50% of patients with cancer are expected to need radiotherapy (RT), and the majority of these are older. To improve outcomes for older patients with cancer, geriatric assessment (GA)...
10.
Haugan K, Halsteinli V, Dohl O, Basso T, Johnsen L, Foss O
Injury . 2021 Feb; 52(11):3434-3439. PMID: 33551261
Aims: To compare costs related to a standardised versus conventional hospital care for older patients after fragility hip fracture and determine whether a shift in hospital care led to cost-shifts...